WPI Press Release Nov 12: The Whittemore Peterson Institute (WPI) has recently published a research study revealing the prevalence of XMRV in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, ME/CFS, or what has most recently been called, X associated neuro-immune disease (XAND).
In response to an overwhelming request for a diagnostic test for XMRV, WPI has temporarily agreed to allow Viral Immune Pathology Diagnostics (VIP Dx, at www.vipdx.com) to begin offering the identical tests that have been extensively validated using the same technology developed by Drs. Vince Lombardi and Judy Mikovits and their colleagues as reported in Science. [That is, VIP Dx, formerly RedLabs USA, indicates it has licensed the XMRV test technology.]
VIP Dx is a small state certified laboratory in Reno, Nevada that was formed in response to the September 11, 2001 crisis which resulted in the cessation of blood sample shipments between the United States and Europe. Faced with the loss of important lab tests impacting patients with neuro-immune diseases, the Whittemore family made the decision to support the lab in Reno.
“Our family made it possible for the lab to not only continue delivering diagnostic tests to doctors, but also help the WPI bring cutting edge biomarkers of disease to this field of medicine, such as the tests for XMRV,” said Annette Whittemore, Founder and President of WPI. “Tests conducted for XMRV, and other tests that support the diagnostic process in this field, will support the continuation of vital work at WPI through our donation of all of our net proceeds.”
XMRV test acceptance commenced at VIP Dx this month. For more information about the XMRV test kit, visit www.vipdx.com.
NOTE: As ProHealth reported on Oct 26, at least one other U.S. lab with a special interest in ME/CFS – Cooperative Diagnostics, LLC – is offering an XMRV test kit and testing service by mail. For details including pricing, click here.